Byron Vaughn
Appearances
- DateMay 6, 2023Please note that this session requires an additional registration fee to attend…
Presenters
- DateMay 7, 2023Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
- DateMay 18, 2024INTRODUCTION: Intestinal microbiota transplantation (IMT) is an effective therapy for recurrent _Clostridioides difficile_ infection (rCDI) and a promising therapy for severe/fulminant CDI non-responsive to antibiotics…